Advancements in neuroscience are reshaping our understanding of the human brain, but significant challenges remain in translating scientific breakthroughs into effective treatments. From overcoming the blood-brain barrier to developing more precise drug delivery methods, researchers and engineers are working to bridge the gap between discovery and patient impact.
In the webinar “Grand Challenges in Neuroscience” from January 21, 2025, Dr. Jacob Hooker, Lurie Family Professor of Radiology and Scientific Director at the Lurie Center for Autism at Massachusetts General Hospital, joins Nick Allan, Bio Services Manager at StarFish Medical, to discuss some of the biggest hurdles in neuroscience today. The conversation explores the complex interplay between chemistry, biology, and medical device engineering, offering insights into the latest innovations in neurotherapeutics, molecular imaging, and non-invasive drug delivery technologies.
Dr. Hooker shares his expertise in using positron emission tomography (PET) and functional MRI to study the molecular mechanisms of brain function and disease. He discusses how cutting-edge imaging techniques are unlocking new ways to diagnose and treat neurological disorders, neurodegenerative diseases, and psychiatric conditions. These tools address some grand challenges in modern neuroscience research.
A major focus of the discussion is the blood-brain barrier, a protective mechanism that makes it difficult to deliver therapeutics directly to the brain. The speakers examine novel strategies to bypass this challenge, including focused ultrasound, molecular engineering, and olfactory-based drug delivery systems. They also explore how medical device innovation plays a crucial role in advancing cell and gene therapy delivery, ensuring safety and efficacy while minimizing risk.
Beyond drug delivery, the webinar covers the growing role of wearables and real-time monitoring technologies in neuroscience. The potential for home-administered or regionally accessible treatments is expanding, with new engineering solutions making these approaches more feasible. Addressing these grand challenges in neuroscience is revolutionizing treatment accessibility.
The discussion also touches on the future of mental health treatments, emerging research in ALS and neurodegenerative disease, and the role of molecular glues and genetic therapies in addressing complex neurological conditions.
Whether you’re involved in medical device development, neuroscience research, or healthcare innovation, this webinar provides invaluable insights into the evolving landscape of brain health technologies.

Grand Challenges in Neuroscience
Solving mysteries of the human brain with drug delivery
Related Resources

For manufacturers of novel devices that can make a significant impact to patient health, the goal of the program is to offer a path to streamlined and potentially faster market entry without sacrificing the rigour around ensuring safety and performance.

When I was starting out in medical devices, the discussion focused on the possibility of an internet of things and the promise of “big data” about everything.

With the release of ISO 14644-5:2025, Cleanrooms and associated controlled environments, Part 5: Operations, the standard places increased emphasis on operational discipline, human factors, and contamination control behaviour.

This article outlines the core elements of the PCCP framework, the types of modifications it applies to, and how the FDA expects manufacturers to use it in practice.
